blank
blank

Have your say: EU AI Act consultation on high-risk systems

European Union flag ERDERA

The European Commission has opened a public consultation to gather feedback on the implementation of the AI Act’s rules concerning high-risk AI systems. The aim is to collect practical examples, clarify open questions, and inform upcoming Commission guidelines on the classification of high-risk systems and related obligations.

Under the AI Act, high-risk AI systems fall into two main categories:

  • Important for product safety under the Union’s harmonised legislation on product safety
  • Those that can significantly affect people’s health, safety, or fundamental rights in specific use cases listed in the AI Act.

The consultation also addresses responsibilities across the AI value chain, helping to define roles and accountability for all actors involved.
The Commission invites input from a wide range of stakeholders, including AI developers and providers, businesses and public sector users, academia and research organisations, civil society and citizens, regulatory and supervisory authorities.

The deadline is 18 July 2025. Learn more.

News & Updates

You might also be interested in

Radka Kaneva and Petia Stratieva, Sofia, March 2026

“National Mirror Groups are essentially a bridge — bringing European developments, standards and opportunities to clinicians and researchers.”

ERDERA interviews Prof. Radka Kaneva and Dr Petia Stratieva, two leading members of Bulgaria’s National Mirror Group (NMG), to explore how the country is working to align its rare disease ecosystem with European developments.
Gdańsk - Medical University of Gdańsk

From Hyderabad to Gdansk: collaborative diagnostic efforts that bridge research and clinical practice to shorten patients’ path to answers

ERDERA joins the Wilhelm Foundation and the Gdansk Medical University and Clinical Centre to strengthen phenotype‑led diagnosis for people living with undiagnosed conditions
Captura de pantalla 2026-04-08 142004

Advancement of Treatments for Rare Diseases

The two-day event will focus on translating research and policy initiatives into tangible benefits for Rare Disease patients through better prevention, diagnosis, and treatment.
European Parliament

European Parliament draft report urges a binding EU rare disease action framework

A legislative own initiative file in the Parliament’s new public health committee sets out what an EU “rare disease action framework” could look like — and why it could change how Europe measures progress for patients.

ERDERA's

search form